Microsatellite Instability as a Biomarker for PD-1Blockade微衛(wèi)星不穩(wěn)定性作為PD-1的生物標(biāo)志物 封鎖

Microsatellite Instability as a Biomarker for PD-1Blockade微衛(wèi)星不穩(wěn)定性作為PD-1的生物標(biāo)志物 封鎖

ID:40850017

大?。?69.05 KB

頁數(shù):9頁

時間:2019-08-08

Microsatellite Instability as a Biomarker for PD-1Blockade微衛(wèi)星不穩(wěn)定性作為PD-1的生物標(biāo)志物 封鎖_第1頁
Microsatellite Instability as a Biomarker for PD-1Blockade微衛(wèi)星不穩(wěn)定性作為PD-1的生物標(biāo)志物 封鎖_第2頁
Microsatellite Instability as a Biomarker for PD-1Blockade微衛(wèi)星不穩(wěn)定性作為PD-1的生物標(biāo)志物 封鎖_第3頁
Microsatellite Instability as a Biomarker for PD-1Blockade微衛(wèi)星不穩(wěn)定性作為PD-1的生物標(biāo)志物 封鎖_第4頁
Microsatellite Instability as a Biomarker for PD-1Blockade微衛(wèi)星不穩(wěn)定性作為PD-1的生物標(biāo)志物 封鎖_第5頁
資源描述:

《Microsatellite Instability as a Biomarker for PD-1Blockade微衛(wèi)星不穩(wěn)定性作為PD-1的生物標(biāo)志物 封鎖》由會員上傳分享,免費在線閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫。

1、ReviewClinicalCancerResearchMicrosatelliteInstabilityasaBiomarkerforPD-1Blockade1232,3JonathanC.Dudley,Ming-TsehLin,DungT.Le,andJamesR.EshlemanAbstractInitialresultsbyLeandcolleagues,whichwerepublishedinwithLynchsyndromeorsomatichypermethylationoftheMLH1theJune25,2015issueoftheNe

2、wEnglandJournalofMedicine,promoter.Theresultisacancerwitha10-to100-foldincreaseinreportsigni?cantresponsesofcancerswithmicrosatelliteinsta-mutations,associatedinthecolonwithpoordifferentiation,anbility(MSI)toanti–PD-1inhibitorsinpatientswhofailedintenselymphocyticin?ltrate,andasu

3、periorprognosis.Diag-conventionaltherapy.This?nding?tsintoabroaderbodyofnosticapproacheshaveevolvedsincetheearly1990s,fromresearchassociatingsomatichypermutationandneoepitoperelyingexclusivelyonclinicalcriteriatoincorporatingpathologicformationwithresponsetoimmunotherapy,withthea

4、ddedfeatures,PCR-basedMSItesting,andimmunohistochemistrybene?tofrelyingonasimple,widelyuseddiagnostictest.ThisforlossofMMRcomponentexpression.TumortypescanbereviewsurveysthepathogenesisandprognosticvalueofMSI,groupedintocategoriesbasedonthefrequencyofMSI,fromdiagnosticguidelinesf

5、ordetectingit,andthefrequencyofMSIcolorectal(20%)andendometrial(22%–33%)tocervical(8%)acrosstumors,withthegoalofprovidingareferenceforitsuseasandesophageal(7%)toskinandbreastcancers(0%–2%).abiomarkerforPD-1blockade.MSIusuallyarisesfromeitherIfinitialresultsarevalidated,MSItesting

6、couldhaveanexpandedgermlinemutationsincomponentsofthemismatchrepairroleasatoolinthearmamentariumofprecisionmedicine.(MMR)machinery(MSH2,MSH6,MLH1,PMS2)inpatientsClinCancerRes;22(4);813–20.ó2016AACR.DisclosureofPotentialCon?ictsofInterestNopotentialcon?ictsofinterestweredisclosed.

7、Editor'sDisclosuresThefollowingeditor(s)reportedrelevant?nancialrelationships:J.R.Grandis—None.CMEStaffPlanners'DisclosuresThemembersoftheplanningcommitteehavenorealorapparentcon?ictsofinteresttodisclose.LearningObjectivesUponcompletionofthisactivity,theparticipantshouldhaveabett

8、erunderstandingofthepathogenesisandclini

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動畫的文件,查看預(yù)覽時可能會顯示錯亂或異常,文件下載后無此問題,請放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫負(fù)責(zé)整理代發(fā)布。如果您對本文檔版權(quán)有爭議請及時聯(lián)系客服。
3. 下載前請仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時可能由于網(wǎng)絡(luò)波動等原因無法下載或下載錯誤,付費完成后未能成功下載的用戶請聯(lián)系客服處理。